Latin America breast cancer genetics study to improve risk predictions
Official title: Latin America Genomics of Breast Cancer Risk Study (LAGENO-BCR)
Funded at University of California at Davis · NIH-11535297 · Data updated 2026-11-12
A large study of diverse Hispanic/Latina and Latin American women aims to improve how well we predict breast cancer risk using genetic information.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $8,640 |
| NIH project number | 3R01CA286650-03S4 |
| Project ID | NIH-11535297 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals of Latin American or Hispanic/Latina ancestry who may be affected by breast cancer risk or who have a family history of breast cancer.
✕Less likely to help
People without breast cancer risk concerns or from non-diverse populations may not directly benefit from the new models.
What this research studies
This project brings together data from thousands of women across Latin America and the U.S. to understand how genetic differences by ancestry affect breast cancer risk. Researchers will combine existing studies to create more accurate risk models that reflect diverse populations. The goal is to produce improved risk assessment tools that help guide screening and prevention for people who are at higher risk due to their ancestry and geography.
Why it matters
Potential benefit: If successful, the study could lead to better, personalized breast cancer risk scores that inform screening and prevention for diverse populations.
How similar studies have gone: Previous diverse-genomics efforts showed that including non-European populations improves predictive power and model accuracy.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Fejerman, Laura — University of California at Davis
- Study coordinator: Fejerman, Laura
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genomic study to understand how genetics and epigenetics shape triple-negative breast cancer in African ancestry
This study looks at how inherited genes and gene activity affect triple-negative breast cancer in people of African ancestry to better understand why outcomes can be worse.
-
Translational breast cancer research to improve treatment options
A comprehensive program at Baylor College of Medicine is focusing on breast cancer; researchers will advance targeted therapies and biomarkers to help patients with aggressive or hard-to-treat forms.
-
Cancer Pain Management for Asian American Breast Cancer Survivors with Depressive Symptoms
A technology-based program helps Asian American breast cancer survivors with depressive symptoms manage chronic pain more effectively from home using a web app and mobile tools.
-
Co-Targeting IL-6 and CDK4/6 to Prevent TNBC in Women Veterans
A study aims to block two cancer-promoting pathways (IL-6 and CDK4/6) to prevent or reduce progression of triple-negative breast cancer in women veterans.
-
Gut bacteria and metabolites linked to breast density and cancer risk
A small, patient-friendly study will explore whether gut bacteria and their byproducts are connected to high breast density, which can raise cancer risk and make screening less accurate.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.